Literature DB >> 23033922

A novel local recycling mechanism that enhances enteric bioavailability of flavonoids and prolongs their residence time in the gut.

Bijun Xia1, Qiong Zhou, Zhijie Zheng, Ling Ye, Ming Hu, Zhongqiu Liu.   

Abstract

Recycling in the gastrointestinal tract is important for endogenous substances such as bile acids and for xenobiotics such as flavonoids. Although both enterohepatic and enteric recycling mechanisms are well recognized, no one has discussed the third recycling mechanism for glucuronides: local recycling. The intestinal absorption and metabolism of wogonin and wogonoside (wogonin-7-glucuronide) was characterized by using a four-site perfused rat intestinal model, and hydrolysis of wogonoside was measured in various enzyme preparations. In the perfusion model, the wogonoside and wogonin were interconverted in all four perfused segments. Absorption of wogonoside and conversion to its aglycon at the upper small intestine was inhibited in the presence of a glucuronidase inhibitor (saccharolactone) but was not inhibited by lactase phlorizin hydrolase (LPH) inhibitor gluconolactone or antibiotics. Further investigation indicated that hydrolysis of wogonoside in the blank intestinal perfusate was not correlated with bacterial counts. Kinetic studies indicated that K(m) values from blank duodenal and jejunal perfusate were essentially identical to the K(m) values from intestinal S9 fraction but were much higher (>2-fold) than those from the microbial enzyme extract. Lastly, jejunal perfusate and S9 fraction share the same optimal pH, which was different from those of fecal extract. In conclusion, local recycling of wogonin and wogonoside is the first demonstrated example that this novel mechanism is functional in the upper small intestine without significant contribution from bacteria β-glucuronidase.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033922      PMCID: PMC3953453          DOI: 10.1021/mp300315d

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  35 in total

1.  Metabolism of flavonoids via enteric recycling: role of intestinal disposition.

Authors:  Jun Chen; Huimin Lin; Ming Hu
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

Review 2.  Coupling of conjugating enzymes and efflux transporters: impact on bioavailability and drug interactions.

Authors:  Eun Ju Jeong; Xing Liu; Xiaobin Jia; Jun Chen; Ming Hu
Journal:  Curr Drug Metab       Date:  2005-10       Impact factor: 3.731

3.  Enterohepatic Circulation of Estrogens.

Authors:  W H Manwaring
Journal:  Cal West Med       Date:  1943-11

4.  Comparison of Coomassie Brilliant Blue protein dye-binding assays for determination of urinary protein concentration.

Authors:  T Marshall; K M Williams
Journal:  Clin Chem       Date:  1987-04       Impact factor: 8.327

5.  Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10.

Authors:  Eun Ju Jeong; Yong Liu; Huimin Lin; Ming Hu
Journal:  Drug Metab Dispos       Date:  2005-03-15       Impact factor: 3.922

Review 6.  A review of cancer chemopreventive agents.

Authors:  M S Levi; R F Borne; J S Williamson
Journal:  Curr Med Chem       Date:  2001-09       Impact factor: 4.530

Review 7.  Intestinal and hepatic glucuronidation of flavonoids.

Authors:  Li Zhang; Zhong Zuo; Ge Lin
Journal:  Mol Pharm       Date:  2007-11-03       Impact factor: 4.939

8.  Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.

Authors:  Tatsuya Nagano; Masahiro Yasunaga; Koichi Goto; Hirotsugu Kenmotsu; Yoshikatsu Koga; Jun-Ichiro Kuroda; Yoshihiro Nishimura; Takashi Sugino; Yutaka Nishiwaki; Yasuhiro Matsumura
Journal:  Clin Cancer Res       Date:  2009-06-09       Impact factor: 12.531

9.  Enteric disposition and recycling of flavonoids and ginkgo flavonoids.

Authors:  Yong Liu; Yan Liu; Yang Dai; Luying Xun; Ming Hu
Journal:  J Altern Complement Med       Date:  2003-10       Impact factor: 2.579

10.  Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Abdelhakim Ahmed-Belkacem; Nazim Ahnou; Laetitia Barbotte; Czeslaw Wychowski; Coralie Pallier; Rozenn Brillet; Ralf-Torsten Pohl; Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2009-12-04       Impact factor: 22.682

View more
  4 in total

1.  Triple Recycling Processes Impact Systemic and Local Bioavailability of Orally Administered Flavonoids.

Authors:  Peimin Dai; Lijun Zhu; Feifei Luo; Linlin Lu; Qiang Li; Liping Wang; Ying Wang; Xinchun Wang; Ming Hu; Zhongqiu Liu
Journal:  AAPS J       Date:  2015-03-12       Impact factor: 4.009

2.  Ciprofloxacin blocked enterohepatic circulation of diclofenac and alleviated NSAID-induced enteropathy in rats partly by inhibiting intestinal β-glucuronidase activity.

Authors:  Ze-Yu Zhong; Bin-Bin Sun; Nan Shu; Qiu-Shi Xie; Xian-Ge Tang; Zhao-Li Ling; Fan Wang; Kai-Jing Zhao; Ping Xu; Mian Zhang; Ying Li; Yang Chen; Li Liu; Lun-Zhu Xia; Xiao-Dong Liu
Journal:  Acta Pharmacol Sin       Date:  2016-05-16       Impact factor: 6.150

3.  Cognitive response to fish oil, blueberry, and combined supplementation in older adults with subjective cognitive impairment.

Authors:  Robert K McNamara; Wilhelmina Kalt; Marcelle D Shidler; Jane McDonald; Suzanne S Summer; Amanda L Stein; Amanda N Stover; Robert Krikorian
Journal:  Neurobiol Aging       Date:  2017-12-12       Impact factor: 4.673

4.  Disposition of flavonoids via recycling: Direct biliary excretion of enterically or extrahepatically derived flavonoid glucuronides.

Authors:  Min Zeng; Rongjin Sun; Sumit Basu; Yong Ma; Shufan Ge; Taijun Yin; Song Gao; Jun Zhang; Ming Hu
Journal:  Mol Nutr Food Res       Date:  2016-04-13       Impact factor: 5.914

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.